ND Capital

ND Capital is a venture capital firm established in 2002 and located in Woodside, California. The firm focuses on investing in disruptive technologies within the life sciences, physical sciences, and data sciences sectors. As a Registered Investment Adviser, ND Capital aims to identify and support innovative ventures that have the potential to create significant advancements in these fields.

Kirill Kuzmichev

Principal

Peter Liddiard

CFO and COO

Aymeric Sallin

Founder and CEO

Ryan Schubert MD

Venture Partner

Luc Bauer Ph.D

Venture Partner

6 past transactions

SiMa.ai

Series B in 2021
SiMa.ai is a machine learning company based in San Jose, California, founded in 2018. It specializes in developing a machine learning platform designed for embedded systems, offering a single-chip solution that supports high-performance computing with low power consumption. The company initially focused on computer vision applications at the embedded edge, providing machine learning solutions with performance metrics ranging from 50 TOPs at 5W to 200 TOPs at 20W. SiMa.ai's technology enables effortless deployment and scaling, allowing businesses to integrate secure machine learning inference alongside traditional computing. Additionally, its solutions include capabilities for detecting security threats, enhancing the safety of embedded applications.

Cytoki

Series A in 2021
CytoKi Pharma ApS, a discovery stage biotech company, develops treatments for epithelial injury based diseases with an unmet medical need. The company was founded in 2019 and is based in Værløse, Denmark.

H55

Venture Round in 2020
H55 S.A. manufactures electric propulsion system and battery management solutions for aircrafts. It offers software and hardware solutions for integrating propeller, transmission systems, electric motors and controllers, energy storage, and pilot interface. The company was founded in 2015 and is based in Sion, Switzerland.

Orca Bio

Series D in 2020
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to these patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

SiMa.ai

Series A in 2020
SiMa.ai is a machine learning company based in San Jose, California, founded in 2018. It specializes in developing a machine learning platform designed for embedded systems, offering a single-chip solution that supports high-performance computing with low power consumption. The company initially focused on computer vision applications at the embedded edge, providing machine learning solutions with performance metrics ranging from 50 TOPs at 5W to 200 TOPs at 20W. SiMa.ai's technology enables effortless deployment and scaling, allowing businesses to integrate secure machine learning inference alongside traditional computing. Additionally, its solutions include capabilities for detecting security threats, enhancing the safety of embedded applications.

ARMO BioSciences

Series B in 2014
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics. The company is based in Redwood City, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.